These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 39216658)

  • 21. Clinical impact of subgrouping ANCA-associated vasculitis according to antibody specificity beyond the clinicopathological classification.
    Deshayes S; Martin Silva N; Khoy K; Yameogo S; Mariotte D; Lobbedez T; Aouba A
    Rheumatology (Oxford); 2019 Oct; 58(10):1731-1739. PubMed ID: 30805643
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum levels of interleukin-32 and interleukin-6 in granulomatosis with polyangiitis and microscopic polyangiitis: association with clinical and biochemical findings.
    Krajewska Wojciechowska J; Kościelska-Kasprzak K; Krajewski W; Morawski K
    Eur Cytokine Netw; 2019 Dec; 30(4):151-159. PubMed ID: 32096477
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetics of ANCA-associated vasculitis: role in pathogenesis, classification and management.
    Trivioli G; Marquez A; Martorana D; Tesi M; Kronbichler A; Lyons PA; Vaglio A
    Nat Rev Rheumatol; 2022 Oct; 18(10):559-574. PubMed ID: 36109667
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Republished: Antineutrophil cytoplasmic antibody-associated vasculitides: is it time to split up the group?
    Millet A; Pederzoli-Ribeil M; Guillevin L; Witko-Sarsat V; Mouthon L
    Postgrad Med J; 2014 May; 90(1063):290-6. PubMed ID: 24737903
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antineutrophil cytoplasmic antibody-associated vasculitides: is it time to split up the group?
    Millet A; Pederzoli-Ribeil M; Guillevin L; Witko-Sarsat V; Mouthon L
    Ann Rheum Dis; 2013 Aug; 72(8):1273-9. PubMed ID: 23606701
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The utility of the ACR/EULAR 2017 provisional classification criteria for granulomatosis with polyangiitis in Korean patients with antineutrophil cytoplasmic antibody-associated vasculitis.
    Yoo J; Kim HJ; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
    Clin Exp Rheumatol; 2018; 36 Suppl 111(2):85-87. PubMed ID: 29185957
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive and ANCA-Negative Patients With Granulomatosis With Polyangiitis (Wegener's): Distinct Patient Subsets.
    Miloslavsky EM; Lu N; Unizony S; Choi HK; Merkel PA; Seo P; Spiera R; Langford CA; Hoffman GS; Kallenberg CG; St Clair EW; Tchao NK; Fervenza F; Monach PA; Specks U; Stone JH
    Arthritis Rheumatol; 2016 Dec; 68(12):2945-2952. PubMed ID: 27428559
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of eosinophilic granulomatosis with polyangiitis during the clinical course of microscopic polyangiitis: A case report.
    Ide H; Shimizu T; Koike Y; Abe K; Shigematsu K; Nishihata S; Kojima K; Ichinose K; Kawakami A
    Medicine (Baltimore); 2022 Nov; 101(44):e31401. PubMed ID: 36343053
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive Granulomatosis With Polyangiitis (Wegener's) Is a Clinically Distinct Subset of ANCA-Associated Vasculitis: A Retrospective Analysis of 315 Patients From a German Vasculitis Referral Center.
    Schirmer JH; Wright MN; Herrmann K; Laudien M; Nölle B; Reinhold-Keller E; Bremer JP; Moosig F; Holle JU
    Arthritis Rheumatol; 2016 Dec; 68(12):2953-2963. PubMed ID: 27333332
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Torasemide-induced Vascular Purpura in the Course of Eosinophilic Granulomatosis with Polyangiitis.
    Frątczak A; Polak K; Miziołek B; Bergler-Czop B
    Acta Dermatovenerol Croat; 2022 Sep; 30(2):116-118. PubMed ID: 36254546
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of MPO-ANCA-mediated oxidative imbalance on renal vasculitis.
    Hilhorst M; Maria AT; Kavian N; Batteux F; Borderie D; Le Quellec A; van Paassen P; Guilpain P
    Am J Physiol Renal Physiol; 2018 Dec; 315(6):F1769-F1776. PubMed ID: 30207165
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relapse rate and renal prognosis in ANCA-associated vasculitis according to long-term ANCA patterns.
    Oristrell J; Loureiro-Amigo J; Solans R; Valenzuela MP; Monsálvez V; Segarra A; Amengual MJ; Marín A; Feijoo C; Tolosa C
    Clin Exp Immunol; 2021 Feb; 203(2):209-218. PubMed ID: 33020895
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Granulomatosis with polyangiitis and microscopic polyangiitis].
    Klapa S; Arnold S; Lamprecht P
    Laryngorhinootologie; 2024 Jul; 103(7):490-499. PubMed ID: 38211619
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Farm Exposure as a Differential Risk Factor in ANCA-Associated Vasculitis.
    Willeke P; Schlüter B; Sauerland C; Becker H; Reuter S; Jacobi A; Schotte H
    PLoS One; 2015; 10(9):e0137196. PubMed ID: 26339905
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic algorithm for antineutrophil cytoplasmic antibody-associated systemic vasculitis.
    Beketova TV
    Ter Arkh; 2018 May; 90(5):13-22. PubMed ID: 30701885
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of anti-glomerular basement membrane antibodies and glomerular neutrophil activation on glomerulonephritis in experimental myeloperoxidase-antineutrophil cytoplasmic antibody vasculitis.
    Kanzaki G; Nagasaka S; Higo S; Kajimoto Y; Kanemitsu T; Aoki M; Nagahama K; Natori Y; Tsuboi N; Yokoo T; Shimizu A
    Nephrol Dial Transplant; 2016 Apr; 31(4):574-85. PubMed ID: 26582929
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ANCA-associated vasculitis - clinical utility of using ANCA specificity to classify patients.
    Cornec D; Cornec-Le Gall E; Fervenza FC; Specks U
    Nat Rev Rheumatol; 2016 Oct; 12(10):570-9. PubMed ID: 27464484
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of antineutrophil cytoplasmic antibody (ANCA) specificity with demographic and clinical characteristics of patients with ANCA‑associated vasculitides.
    Wójcik K; Masiak A; Jeleniewicz R; Jakuszko K; Brzosko I; Storoniak H; Kur-Zalewska J; Wisłowska M; Madej M; Hawrot-Kawecka A; Głuszko P; Kucharz EJ;
    Pol Arch Intern Med; 2022 Mar; 132(3):. PubMed ID: 34985235
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aggravation of anti-myeloperoxidase antibody-induced glomerulonephritis by bacterial lipopolysaccharide: role of tumor necrosis factor-alpha.
    Huugen D; Xiao H; van Esch A; Falk RJ; Peutz-Kootstra CJ; Buurman WA; Tervaert JW; Jennette JC; Heeringa P
    Am J Pathol; 2005 Jul; 167(1):47-58. PubMed ID: 15972951
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alternative complement pathway in the pathogenesis of disease mediated by anti-neutrophil cytoplasmic autoantibodies.
    Xiao H; Schreiber A; Heeringa P; Falk RJ; Jennette JC
    Am J Pathol; 2007 Jan; 170(1):52-64. PubMed ID: 17200182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.